Dr. Douglas Roblin is a Senior Investigator at TCHR whose research focuses on a broad range of population-based issues. His principal research interests center on how organizational and financial characteristics affect patient outcomes. He has over two decades' experience working as a Statistician and Health Economist in health care organizations.

Dr. Roblin is a Co-Investigator for the Impact of Health Promotion Programs on MCO Family Health project, which is assessing how psychosocial circumstances and worksite characteristics affect employees' health. He is also a Co-Investigator on the HMO Research Network's CERT II program, which conducts pharmacoepidemiology and pharmacoeconomics research projects across 9 managed care organizations. He was the lead investigator on a CERT I project, which analyzed the impact of medication cost-sharing increases on use of oral hypoglycemics.

Dr. Roblin served as the Principal Investigator for an Improving Chronic Illness Care Initiative project, which evaluated an interactive voice recognition and response system for collecting data from patients with congestive heart failure. He also served as Co-Investigator for the Organization Culture, Workforce Characteristics, and Quality of Care in a Primary Care Practice, which examined the associations between organizational culture, workforce characteristics, and quality of care in a managed care organization. Dr. Roblin holds a PhD in Anthropology from the University of Michigan and a MA in Anthropology from the University of Chicago. He serves as a manuscript reviewer for various peer-reviewed journals, including American Journal of Managed Care and Medical Care.

Dr. Roblin served on the Editorial Committee for the Journal of Quality Improvement and participated on the steering committee for the American Diabetes Association's Diabetes Physician Recognition Program from 1998-2004. In addition to his position at CHR, Dr. Roblin is also an Adjunct Assistant Professor in Health Policy and Management in the Rollins School of Public Health at Emory University.

Current Studies:

	Enhanced Identification of Adverse Drug Events (Suppl to ADR—CERT II)
	Enhancing an HMO Tumor Registry with NDI Mortality Data (CRN)
	Hemodialysis Vascular Access Trends and Medication Use Among HMO Patients with Chronic Kidney Disease

Recently Completed Studies:

	A Prospective Observational Cohort Study of Patients Receiving Alosetron (Lotronex®) in the HMO Research Network
	Cluster Randomized Trials: Ethical Issues and Practical Constraints
	Enhanced Identification of Adverse Drug Reactions (ADR)—(CERT II)
	Epidemiological Studies of Adverse Effects of Marketed Drugs—FDA Task Orders
	Impact of Health Promotion Programs on Managed Care Organization (MCO) Family Health
	Improving Adherence to Preventive Therapy After Myocardial Infarction (AMI)—CERTII
	Preventing Medication Errors Among Cancer Patients in the Outpatient Setting (CERT II)

E-mail: Douglas.Roblin@kp.org